Licences issued by the National Health and Medical Research Council's (NHMRC) Embryo Research Licensing Committee (ERLC) are subject to conditions.
ELRC maintains a public database containing particular information in relation to each licence. The database is available in Table 1.
ERLC is required by section 29 of the Research Involving Human Embryos Act 2002 (RIHE Act) to maintain a public database containing the following information in relation to each general licence and each mitochondrial donation licence:
- the name of the person to whom the licence was issued
- for a general licence – a short statement about the uses of excess ART embryos or human eggs, creation or uses of other embryos, that are authorised by the licence
- for a mitochondrial donation licence – a short statement about the nature of the uses of excess ART embryos or human eggs, and creations or uses of other embryos or zygotes, that are authorised by the licence
- for a general licence – the number of excess ART embryos or human eggs, and the number of other embryos authorised to be created in respect of which use is authorised by the licence
- for a mitochondrial donation licence – the number of excess ART embryos or human eggs, and the number of other embryos authorised to be created in respect of which use is authorised by the licence
- any conditions to which the licence is subject
- the date on which the licence was issued
- the period throughout which the licence is to remain in force.
Information made public must not be such as to disclose confidential commercial information.
Licence conditions
Licences issued by ERLC are subject to conditions. Licences are also subject to the provisions of the RIHE Act and the Prohibition of Human Cloning for Reproduction Act 2002. The sections below describe Standard and Special Licence conditions.
Standard conditions
The Standard conditions is available in the Downloads section (below). Standard conditions apply to all licences unless a particular standard condition is specifically excluded by the Special conditions for a licence.
Special conditions
Special licence conditions relate to a particular licence and include conditions about the number of excess ART embryos or eggs authorised for use, the number of other embryos authorised to be created or used, the people authorised to create and/or use them and the authorised sites, as well as any other special conditions determined by ERLC.
See the table below for details of the licences and special conditions.
| Licence no. | Organisation | Licence title | Date of issue | Status |
|---|---|---|---|---|
| 309718 v27 (PDF 210 KB) | Genea Limited | Use of excess ART embryos and clinically unusable eggs for validation of an IVF device | 8 December 2011 | Current to 7 December 2024 |
| 309719 v26 (PDF 200 KB) | Genea Limited | Use of excess ART embryos for the development of improved IVF culture media | 28 March 2012 | Current to 28 March 2024 |
| 309727 v1 (PDF 190 KB) | Melbourne IVF Pty Ltd | Comprehensive chromosomal analysis of human preimplantation embryos | 15 August 2022 | Current to 14 August 2025 |
| 309729 v1 (PDF 190 KB) | Monash University | The generation and study of a novel in-vitro model of human blastocysts (‘iBlastoids’) | 19 October 2022 | Current to 18 October 2025 |
| Licence no. | Organisation | Licence title | Date of issue | Status |
|---|---|---|---|---|
| 309700 v3 (PDF 100 KB) | Monash IVF | Use of excess ART embryos for training in embryo biopsy | 1 March 2005 | Expired |
| 309701 v20 (PDF 230 KB) | Sydney IVF | Improvement in laboratory conditions for embryo culture | 16 April 2004 | Expired |
| 309702A v19 (PDF 220 KB) | Sydney IVF | Effect of an additive on embryo culture: analysis of growth and epigenetic programming | 16 April 2004 | Expired |
| 309702b v43 (PDF 200 KB) | Genea Limited | Development of Methods for Preimplantation Genetic and Metabolic Evaluation of Human Embryos | 16 April 2004 | Expired |
| 309703 v47 (PDF 210 KB) | Genea Limited | Development of Human Embryonic Stem (ES) Cells | 16 April 2004 | Expired |
| 309704 v8 (PDF 200 KB) | Melbourne IVF Pty Ltd | Development of testing procedures for unbalanced chromosome errors in human embryos | 16 April 2004 | Expired |
| 309707 v5 (PDF 130 KB) | Monash University | Derivation of embryonic stem cell lines from the human embryo | 21 December 2004 | Expired |
| 309708 v6 (PDF 100 KB) | IVF Australia Pty Ltd | A collaborative project between IVF Australia and the Diabetes Transplant Unit, Prince of Wales Hospital to derive human embryonic stem cell lines for the treatment of diabetes | 5 November 2004 | Expired |
| 309709 v9 (PDF 170 KB) | Melbourne IVF Pty Ltd | A collaborative project between Melbourne IVF Pty Ltd and Stem Cell Sciences Pty Ltd to derive human embryonic stem cell lines | 11 June 2004 | Expired |
| 309710 v38 (PDF 220 KB) | Genea Limited | Derivation of human embryonic stem cells from embryos identified through preimplantation genetic diagnosis to be affected by known serious monogenic conditions | 7 May 2007 | Expired |
| 309712 v15 (PDF 80 KB) | Genea Limited | Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from human cumulus cells into clinically unusable human eggs. | 16 September 2008 | Expired |
| 309713 v15 (PDF 80 KB) | Genea Limited | Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from adult human fibroblasts into clinically unusable human eggs. | 16 September 2008 | Expired |
| 309714 v15 (PDF 80 KB) | Genea Limited | Reproducible production of human embryonic stem cell lines from somatic cell nuclear transfer (SCNT) of nuclei from previously established human embryonic stem cell lines into clinically unusable human eggs. | 16 September 2008 | Expired |
| 309716 v5 (PDF 130 KB) | Fertility Australia Trust trading as Fertility East Assisted Conception Clinic and Monash Institute of Medical Research | Production of human embryonic stem cell lines from parthenogenetic activation of matured human eggs obtained from clinically unusable human eggs | 29 June 2011 | Expired |
| 309720 v3 (PDF 100 KB) | Fertility Australia Trust trading as Fertility East Assisted Conception Clinic and Division of Biological Engineering, Faculty of Engineering, Monash University | Production of human embryonic stem cell lines from parthenogenetic activation of human eggs obtained from ovaries removed prophylactically from women at risk for developing cancer | 15 July 2013 | Expired |
| 309722 v6 (PDF 90 KB) | Monash IVF Pty Ltd | Optimising embryo-endometrial interactions to improve pregnancy success during IVF | 11 December 2013 | Expired |
| 309723 v13 (PDF 230 KB) | Melbourne IVF Pty Ltd | Use of excess ART embryos for blastocyst-stage biopsy training | 19 December 2014 | Expired |
| 309724 v4 (PDF 225 KB) | IVF Australia Pty Ltd | Use of excess ART embryos for blastocyst-stage biopsy training | 21 April 2017 | Expired |
| 309725 v7 (PDF 170 KB) | TasIVF Pty Ltd | Use of excess ART embryos for blastocyst-stage embryo biopsy training | 1 September 2017 | Expired |
| 309726 v8 (PDF 170 KB) | Genea Limited | Use of excess ART embryos for training in an alternate biopsy method (day five hatch and biopsy) | 3 June 2019 | Expired |
